Genelabs Technology (GNLB)
Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of pharmaceutical products to improve human health. It is developing Prestara (prasterone), an investigational drug for women with systemic lupus erythematosus. The company also pursues drug discovery of novel anti viral compounds for the treatment of hepatitis C virus infections and advances pre clinical development of compounds in this program. Its products in pre clinical stage include HCV NSSb Polymerase and HCV NSSa for the treatment of Hepatitis C virus infection. Genelabs Technologies, in partnership with Glaxosmithkline, is also developing HEV Vaccine for the prevention of disease...
read more
QUOTE
As of 12:16PM EDT May 24, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
GNLB |
| SIC: |
-
|
| State location: |
CA |
| Sector: |
- |
| State of Inc: |
CA |
| Employees: |
76 |
| Type: |
NASDAQ |
GENELABS TECHNOLOGY (GNLB) MESSAGE BOARD
